Clinical Trial Update: Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating daunorubicin and cytarabine with or without uproleselan in older adults with acute myeloid leukemia undergoing intensive i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Uproleselan (uproleselan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-21